or cannot tolerate drug side effects. However, it is hard to choose among current widely accepted surgery options, including percutaneous rhizotomies (PR), stereotactic radiosurgery (SRS), and microvascular decompression (MVD) due to the difficulty of performing randomized controlled trials of these surgical techniques. Moreover, inconsistent criteria of facial pain relief were frequently used in different studies.
maintenance of persistent pain relief are also identified. The present study also followed the surgical trigeminal neuralgia scoring checklist (1) , and the results could enhance comparability with other researches.
█ mATERIAl and mEThODS

Patient Population
During the period from July 1991 to December 2011, the senior author (Zhao W) performed 539 MVDs for patients with idiopathic TN at the Department of Neurosurgery, RuiJin Hospital, Shanghai JiaoTong University School of Medicine (Shanghai, China). Of these patients, 49 were excluded due to a history of multiple sclerosis (3 patients), bilateral symptoms (16 patients), previous MVD (17 patients) or imprecise description about their pain characteristics (13 patients), 65 were excluded due to death of unrelated causes (8 patients) or insufficient follow-up records (57 patients). Finally, a total of 425 patients who had a failed drug management history were therefore enrolled in this study. All patients fulfilled the diagnostic criteria outlined by The International Classification of Headache Disorders, 3 rd edition (14) . All aspects of this study were approved by the Rui Jin Clinic Institutional Review Board.
Surgical Technique
All operations were performed using a lateral suboccipital retrosigmoid approach as previously described in detail (22) . After the dura was opened and the cerebrospinal fluid (CSF) was drained slowly, appropriate brain relaxation can be achieved with no retractor. Next, the entire trigeminal root was dissected free from the surrounding adhesive arachnoid membranes and examined from the REZ to the porus of Meckel's cave. Teflon was then implanted between the fifth nerve and all offending vessels. If no neurovascular conflict existed, only nerve combing was performed.
Data Collection and Outcome Criteria
Patient characteristics, pain properties, surgical findings, and operative results were recorded in a database while hospitalization. Pain outcomes and adverse effects related to the operation were first assessed through outpatient followup examinations, and later through yearly telephone surveys that was carried out by an investigator who was blinded to the patient's history and diagnosis (Wei Y). Typical TN was defined as characterized paroxysmal, electrical, shooting, or stabbing pain, and atypical TN was defined as episodic pain with intervals of persistent background facial pain. Outcome was assessed using the Barrow Neurological Institute pain scale (BNI) (7) . Facial pain was considered as cured upon complete pain relief with no medications (BNI I~II), and as failed when pain continued or recurred (BNI III~V). Recurrence was defined as the return of facial pain to BNI grade IV and V after initial pain relief.
Potential Predictors of Outcome
The following potential prognostic factors were considered in the present study: (a) patient characteristics, including age at surgery, gender, hypertension, and previous failed surgery procedures other than MVD; (b) factors related to neuralgia, including the side involved, topography of the trigeminal nerve, symptom duration, and clinical presentation (typical vs. atypical); (c) factors related to intraoperative findings, such as arteries, veins, or mixed type, and number of conflicted vessels.
Statistical Analysis
Statistical analysis was performed with SPSS version 20.0 (SPSS Inc., Chicago, IL, USA) and GraphPad Prism 5.0 (GraphPad Software, Inc., La Jolla, CA, USA). Kaplan-Meier curves were calculated to determine the ratio of patients who responded to the operation. Correlations between prognostic factors and outcomes were assessed by Fisher's exact test, and further analyzed by Cox proportional-hazards regression. Results are shown as hazard ratios (HR) with 95% confidence intervals (95%CI).
█ RESulTS
Patient Characteristics
Patient characteristics are shown in Table I . Among the 425 cases, 342 (80.47%) had typical clinical presentation, 83 (19.53%) presented with concomitant persistent facial pain between episodes, and most progressed from purely paroxysmal neuralgia over time. Hypertension was observed in 89 patients (20.94%). Three hundred eighty-four patients (90.35%) had clear neurovascular conflicts, arterial compression was seen in 310 patients (72.94%); 27 (6.35%) had pure venous compression, and 50 (11.76%) had compression of both artery and vein, no compressed vessel was found in 41 patients (9.6%). Of note, four female patients (0.94%) had a family history of TN, with one or both parents affected.
Facial Pain Outcome
At the time of discharge, complete pain relief was seen in 396 patients (93.18%), while the other 29 (6.82%) experienced an inadequate reduction in facial pain; 62 (15.66%) developed recurrent pain during the follow-up period (mean=8.9 years; range: 2.6-23 years). Among the 91 failed cases (21.41%), adequate pain control was eventually achieved in 39 by pharmacologic treatment, in 15 by additional SRS, and in 11 by PR, while 26 patients (6.12%) experienced persistent facial pain even after various treatments. Since the length of the follow-up time varied between patients, long-term outcome was assessed by generating a Kaplan-Meier survival curve, at the 1-year follow-up evaluation, 89.3% of patients were cured; at 3, 5, and 8 years, 80.5%, 75.6%, and 71.2% of patients were cured respectively ( Figure 1 ).
Prognostic Factors
In the univariate analysis, patients who were older (≥60 years), or had hypertension, typical clinical presentation, arterial compression, and a single offending vessel had significantly better outcome. However, Cox regression analysis suggested that only patients with typical symptoms (HR=0.279, 95% CI: 0.173-0.451; p<0.0001), pure arterial compression (HR=0.213, 95% CI: 0.075-0.601; p=0.004), or who were ≥ 60 years (HR=1.655, 95% CI: 1.066-2.568; p=0.025) had an excellent outcome (Table II, Figures 2,3 , and 4).
Complications
Postoperatively developed permanent cranial nerve impairment and general surgery complications are listed in Table III . Persistent facial sensory dysfunction (facial numbness, hypoesthesia) was seen in 19 patients (4.47%) while four (0.94%) had hearing impairment. Wound infection, mostly minor, occurred in nine patients (2.12%); two (0.47%) had CSF leakage from the wound or rhinorrhea that required surgical repair. One patient (0.24%) developed a bilateral frontal epidural hematoma immediately after the operation that was removed by emergency operation, after which the patient fully recovered. Another patient (0.24%) developed delayed cerebellopontine angle hematoma, and died 5 days after the operation despite undergoing clearance by craniotomy. Hence, the mortality rate in this study was 0.24%.
█ DISCuSSION
MVD is widely acknowledged as an effective method for TN treatment. However, alternative surgical methods such as PR and SRS also exist, and there is still no consensus regarding the most appropriate treatment.
The present study examined 425 consecutive patients who underwent MVD of the trigeminal nerve between 1991 and 2011. The Kaplan-Meier survival curve shows cured rates of 89.3% at 1 year, 80.5% at 3 years, and 71.2% at 8 years with a mean follow-up time of 8.9 years after MVD. These results are consistent with the reported range of 63% to 84% found in other studies (22, 26, 28, 32, 40) . In contrast, only 45.3%-66% of patients benefited from PR 5 years postoperatively (5, 17, 25, 30, 38) , and 34%-56% of patients experienced sustained pain relief 3 years after SRS (10, 21, 31) . Thus, patients who underwent MVD had the highest cured rate at follow-up as compared to those who were treated with other surgical methods.
Regarding the safety of the various surgical procedures, only MVD involves craniotomy. While the incidence of complications has decreased in recent years due to a refinement of the surgical technique, including the use of improved microscopes and precision instruments (40) , permanent cranial injury and general complications related to the operation were seen in 8.47% of patients in this study, while the mortality rate was 2.4%. A higher incidence of adverse effects associated with PR and SRS including temporary facial sensory dysfunction has been reported by many studies, but severe complications such as corneal perforation rarely occurred (5, 17, 21, 25, 30, 31, 38 Potential prognostic factors have been investigated in previous studies, including age at the time of surgery (34, 35) , gender (13, 18, 35) , the side involved (32, 35) , symptom duration (2, 4, 18, 20, 34, 35) , previous failed surgical procedures (2, 6, 33, 35, 36) , topography of the trigeminal nerve (24, 32, 35) , clinical presentation (23, 24) , and type of compressing vessel (6, 13, 16) . Here, the positive predictors of long-term outcome were older age (≥ 60 years), typical clinical presentation, and arterial vascular compression. These findings may help surgeons in choosing more suitable MVD candidates.
The present data suggest that patients with typical TN tend to have a better outcome, consistent with most published results (3, 20, 24, 27, 28, 37, 40) , while an atypical clinical presentation did not have a negative impact on long-term outcome (32) . This distinctive finding could be due in part to the study protocol, which excluded patients without offending vessels, and patients with no vessel compression were more likely to exhibit atypical pain symptoms and had worse outcomes than those with clear neurovascular conflicts (23) .
Previous prognostic studies have suggested that the type of conflicted vessel observed intraoperatively affects long-term outcome after MVD, and arterial vascular compression was believed to be associated with a persistent pain-free state (3, 20) . The same results were found in our study. The reason for this could be that arteries are more easily separated from the fifth nerve as compared to cases of venous or mixed contact. In the present cohort, patients with no visible neurovascular contact had the poorest outcome, despite the nerve combing performed.
Contrary to most studies, here, a better outcome was observed among older (≥ 60 years) rather than younger patients. According to surgical records from our cases, more adequate nerve decompression can be achieved in older patients, since they were more likely to have a spacious corridor and higher prevalence of arteriosclerosis than younger patients. On the other hand, given a similar probability of recurrence, the exposure time is shorter in older patients, and they should therefore not be excluded from MVD if they are in good medical condition.
Unexpectedly, four female patients (0.94%) had a family history of TN, with no multiple sclerosis, Charcot-Marie-Tooth neuropathy, or skull base abnormalities detected. All four cases had clear vascular compression, the outcome was excellent in three and poor in one case. Although there is ongoing debate about the best treatment approach (9, 29) , the results of this study suggest that as for patients with idiopathic TN, familial TN cases can also benefit from MVD.
█ CONCluSION
This study examined the long-term effectiveness and safety of MVD for idiopathic TN, and found pain relief that endured for at least 8 years in 71.2% of MVD cases. Statistically significant predictors for excellent long-term outcome are: Typical clinical presentation, arterial neurovascular compression, and older age (≥ 60 years). Symptom duration and previous failed procedures had no effect on MVD prognosis. These findings should contribute to the appropriate selection of MVD candidates, while patients should also be informed about the efficiency and risks of alternative treatments to aid in decisionmaking.
